PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.38%
Revenue growth at 75-90% of QCOM's 1.58%. Bill Ackman would push for innovation or market expansion to catch up.
2.44%
Gross profit growth at 50-75% of QCOM's 3.40%. Martin Whitman would question if cost structure or brand is lagging.
1.49%
EBIT growth 1.25-1.5x QCOM's 1.34%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
4.16%
Operating income growth above 1.5x QCOM's 1.34%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
0.83%
Net income growth under 50% of QCOM's 15.04%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.96%
EPS growth under 50% of QCOM's 16.13%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.98%
Diluted EPS growth under 50% of QCOM's 15.69%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
14.47%
Similar OCF growth to QCOM's 15.87%. Walter Schloss would assume comparable operations or industry factors.
11.93%
FCF growth 50-75% of QCOM's 18.08%. Martin Whitman would see if structural disadvantages exist in generating free cash.
66.03%
10Y revenue/share CAGR under 50% of QCOM's 229.66%. Michael Burry would suspect a lasting competitive disadvantage.
37.03%
5Y revenue/share CAGR at 50-75% of QCOM's 73.75%. Martin Whitman would worry about a lagging mid-term growth trajectory.
14.40%
3Y revenue/share CAGR under 50% of QCOM's 88.45%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
164.44%
10Y OCF/share CAGR at 50-75% of QCOM's 295.43%. Martin Whitman might fear a structural deficiency in operational efficiency.
86.38%
5Y OCF/share CAGR at 50-75% of QCOM's 138.85%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
21.04%
3Y OCF/share CAGR under 50% of QCOM's 115.08%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
301.53%
Net income/share CAGR above 1.5x QCOM's 190.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
118.16%
5Y net income/share CAGR 1.25-1.5x QCOM's 82.90%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
30.19%
Below 50% of QCOM's 117.69%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
36.59%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
28.13%
Positive 5Y equity/share CAGR while QCOM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
21.31%
Positive short-term equity growth while QCOM is negative. John Neff sees a strong advantage in near-term net worth buildup.
688.88%
10Y dividend/share CAGR above 1.5x QCOM's 215.71%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
167.47%
5Y dividend/share CAGR above 1.5x QCOM's 27.96%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
64.28%
3Y dividend/share CAGR above 1.5x QCOM's 10.22%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
3.90%
Our AR growth while QCOM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
0.38%
Inventory shrinking or stable vs. QCOM's 17.43%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
12.96%
Asset growth above 1.5x QCOM's 4.31%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.95%
75-90% of QCOM's 10.53%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
23.80%
Debt growth far above QCOM's 0.03%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-0.77%
Our R&D shrinks while QCOM invests at 4.72%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.06%
We cut SG&A while QCOM invests at 7.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.